Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆

F Lordick, F Carneiro, S Cascinu, T Fleitas… - Annals of …, 2022 - annalsofoncology.org
More than 1 million (1 089 103) new cases of gastric cancer were estimated globally in
2020, resulting in 768 793 deaths. 1 These burden estimates will continue to increase due to …

Familial and hereditary gastric cancer, an overview

F Carneiro - Best Practice & Research Clinical Gastroenterology, 2022 - Elsevier
There are three major hereditable syndromes that affect primarily the stomach: hereditary
diffuse gastric cancer (HDGC), gastric adenocarcinoma and proximal polyposis of the …

Cancer progress and priorities: gastric cancer

P Alagesan, JC Goodwin, KS Garman… - … , Biomarkers & Prevention, 2023 - AACR
Gastric cancer, the fifth leading cause of cancer worldwide, is estimated to be responsible for
approximately 1.4% of all new cancers and 1.8% of all cancer-related deaths in the United …

[HTML][HTML] Hereditary gastric cancer: single-gene or multigene panel testing? A mono-institutional experience

M Calvello, M Marabelli, S Gandini, E Marino… - Genes, 2023 - mdpi.com
Gastric cancer (GC) has long been a 'Cinderella'among hereditary cancers. Until recently,
single-gene testing (SGT) was the only approach to identify high-risk individuals. With the …

[HTML][HTML] Histone deacetylase functions in gastric cancer: therapeutic target?

A Badie, C Gaiddon, G Mellitzer - Cancers, 2022 - mdpi.com
Simple Summary Our knowledge about the identity of many cancers has increased greatly
during the last years and progress in their early identification as well as treatment options …

[HTML][HTML] Solving the genetic aetiology of hereditary gastrointestinal tumour syndromes–a collaborative multicentre endeavour within the project Solve-RD

AK Sommer, IBAW Te Paske, J Garcia-Pelaez… - European journal of …, 2022 - Elsevier
Background Patients and families with suspected, but genetically unexplained (unsolved)
genetic tumour risk syndromes lack appropriate treatment and prevention, leading to …

2022 年度胃癌研究和诊疗新进展

蒋金玲, 周尘飞, 王超, 赵丽琴, 吴珺玮, 张俊 - 中国癌症杂志, 2023 - china-oncology.com
胃癌是中国高发的消化道恶性肿瘤之一, 5 年相对生存率在40% 左右, 具有早诊率低,
肿瘤负荷大, 异质性强和患者预后差等特点. 近20 年, 多学科团队诊疗模式, 个体化精准决策成为 …

Uso de paneles de genes en pacientes con alto riesgo de cáncer digestivo hereditario: documento de posicionamiento de la AEG, SEOM, AEGH y consorcio IMPaCT …

S Carballal, F Balaguer, L Bujanda, G Capellá… - Gastroenterología y …, 2024 - Elsevier
Este documento de posicionamiento, auspiciado por la Asociación Española de
Gastroenterología, la Sociedad Española de Oncología Médica, la Asociación Española de …

Study on TFF1 and PALB2 gene variants associated with gastric carcinoma risk in the Chinese Han population

W Zou, Q Zhang, R Sun, X Li, S He - Cancer Epidemiology, 2023 - Elsevier
Objective Gastric carcinoma (GC) has received extensive attention due to its complex
pathogenesis. Studies have shown that the expression of Trefoil factor 1 (TFF1) and Partner …

Advanced progress in research and diagnosis of gastric cancer in 2022

J Jinling, Z Chenfei, W Chao, Z Liqin… - China …, 2023 - china-oncology.com
Gastric cancer is one of the malignant tumors with high incidence in China, with a 5-year
relative survival rate of about 40%, which is characterized by low early diagnosis rate, large …